Andrew Cheng - Mar 10, 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Signature
/s/ Jonathan Young, Attorney-in-Fact
Stock symbol
AKRO
Transactions as of
Mar 10, 2023
Transactions value $
-$74,160
Form type
4
Date filed
3/14/2023, 04:18 PM
Previous filing
Mar 3, 2023
Next filing
Apr 5, 2023

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.